Sign in

CIK 0001053369

  • Non-accelerated filer
  • Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
Operating
EIN
223542636
Phone
+1 201-750-2646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
  1. 4 Grant or award Director acquired 58,475 shares (grant or award)
  2. 4 Grant or award Chairman of Board acquired 87,711 shares (grant or award)
  3. 4 Grant or award CFO, Secretary, Treasurer acquired 87,711 shares (grant or award)
  4. 4 Grant or award President & CEO acquired 2,046,554 shares (grant or award)
  5. 4 Conversion Chief Scientific Officer acquired 2,833,333 shares (conversion)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy CEO & President bought 700,000 shares at an average $0.31 ($216,341)
  12. 4 Conversion Chairman of the Board acquired 6,060,000 shares (conversion)
  13. 4 Derivatives Options or other derivatives
  14. 4 Conversion Director acquired 12,423 shares (conversion)
  15. 4/A Conversion Chairman of the Board acquired 375,000 shares (conversion)
  16. 4 Conversion Chairman of the Board acquired 375,000 shares (conversion)
  17. 4 Open-market sale Director sold 329,437 shares at $0.38 ($125,944)
  18. 4 Open-market sale Director sold 147,664 shares at $0.41 ($60,542)
  19. 4 Open-market sale Director sold 190,172 shares at $0.43 ($81,165)
  20. 4 Derivatives Options or other derivatives

Page 6 of 26 · 511 filings